HomepageEarnings Events Newsdesk 2 hours ago Eversource Energy (ES) Eversource Statement on Proposed Final Decision to Approve Aquarion Sale Eversource Energy (NYSE: ES) FY 2026 Other Release « Incyte Corporation (INCY) Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) Newsdesk: